FDAFDA · Food and drugs·Recall number D-0454-2023
DIBUCAINE 1% HEMORRHOIDAL OINTMENT, 1 oz. (28 gm), Manufactured for: Akron Pharma Inc. Fairfield NJ 07004, NDC 71399-2829-1
Published March 15, 2023 · Recall initiated: February 17, 2023
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Incorrect or Missing Lot and/or Exp Date
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- DIBUCAINE
- Manufacturer
- Akron Pharma, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 2206016, Exp. date 05/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.